Category Fast answers

DETERMINE THE PARTIES RESPONSIBLE FOR REGULATING COMPOUNDING PHARMACIES UNDER THE CURRENT REGULATORY SCHEME, THE ACTIONS THAT EITHER THESE PARTIES OR THE FDA COULD / SHOULD HAVE TAKEN IN THIS SCENARIO, AND WHETHER PHARMACARE COULD FACE LEGAL EXPOSURE SURROUNDING ITS PRACTICES.

DETERMINE THE PARTIES RESPONSIBLE FOR REGULATING COMPOUNDING PHARMACIES UNDER THE CURRENT REGULATORY SCHEME, THE ACTIONS THAT EITHER THESE PARTIES OR THE FDA COULD / SHOULD HAVE TAKEN IN THIS SCENARIO, AND WHETHER PHARMACARE COULD FACE LEGAL EXPOSURE SURROUNDING ITS PRACTICES.…